LLIT Lianluo Smart Ltd

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

Commission File Number     001-34427

¨ Form 10-K     x Form 20-F       ¨ Form 11-K      ¨ Form 10-Q      ¨ Form 10-D      ¨ Form N-SAR

¨ Form N-CSR

For Period Ended: December 31, 2015

For the Transition Period Ended: _______________________________________

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates: ______________________

PART I – REGISTRANT INFORMATION

PART II – RULE 12b-25 (b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25 (b), the following should be completed. (Check box if appropriate)

PART III – NARRATIVE

State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed within the prescribed time period.

The Registrant is filing this Form 12b-25 with respect to its Annual Report on Form 20-F for the period ended December 31, 2015 because it needs additional time to finalize the financial reports to be included and the MD&A discussion based upon such financial reports, and to clarify certain information regarding subsequent events, in part due to significant changes in operations in the second half of 2015 and corporate developments in the first part of 2016.

PART IV – OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

x Yes      ¨ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

x Yes      ¨ No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

Our revenues mainly come from medical products and mobile telemedicine. For the years ended December 31, 2015, 2014 and 2013, our total revenues from continuing operation amounted to approximately $1.32 million, $4.06 million and $7.40 million, respectively. Our revenues are subject to value added tax (“VAT”), sales returns and trade discounts. We deduct these amounts from our gross revenues to arrive at our total revenues. Our net loss attributable to the Company for the year ended December 31, 2015 was approximately $(35.96) million. Our net income attributable to the Company for the years ended December 31, 2014 and 2013 was approximately $1.00 million and $2.00 million, respectively.

The sales of Dehaier’s traditional medical device business declined significantly during the recent years. As a result, Dehaier started to develop a sleep respiratory business in 2013 to compete in an increasingly challenging market with new competitors. Since the sleep respiratory business is still at the developmental stage, the Company did not generate significant sales from its sleep respiratory operation in 2015. To try to make the Company’s future continuing operations profitable, the Company plans the following events:

Dehaier Medical Systems Limited

(Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024

Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024